The proteomics study by Capello et al. showed that ENO1 silencing can regulate some integrins expression in a human pancreatic cancer cell line, namely CFPAC-1 (Supplementary Fig. 6A)24. This evidence concerns the gene ENO1 and familial pancreatic carcinoma.